After sertraline dissociates from the serotonin transporter (SERT) without further dosing, where does the unbound drug distribute and how is it eliminated?

Sertraline Distribution and Elimination After SERT Dissociation

Immediate Distribution After Unbinding

Once sertraline dissociates from SERT without further dosing, the unbound drug redistributes extensively into lipid membranes throughout the body and undergoes hepatic metabolism before renal and fecal elimination. 1

After unbinding from SERT, sertraline follows several simultaneous pathways:

Membrane Redistribution and Tissue Sequestration

• Sertraline accumulates massively in lipid membranes at concentrations at least 18-fold higher than in aqueous compartments, creating a large reservoir that slowly releases drug back into circulation 2
• The drug is highly lipophilic and 98% protein-bound in plasma, which facilitates extensive tissue distribution rather than immediate elimination 1
• Unbound sertraline equilibrates between cytoplasm, endoplasmic reticulum, and plasma membranes within seconds to minutes, but the membrane-bound fraction serves as a depot that prolongs drug presence 2

Hepatic Metabolism Pathways

The primary fate of unbound sertraline is extensive first-pass and ongoing hepatic metabolism 1, 3:

• N-demethylation is the principal initial metabolic pathway, forming N-desmethylsertraline (which has a much longer half-life of 62-104 hours compared to sertraline's 26 hours) 1
• Both sertraline and its metabolite undergo oxidative deamination, subsequent reduction, hydroxylation, and glucuronide conjugation 1
• Less than 5% of sertraline remains unchanged in plasma; the vast majority exists as metabolites 1

Elimination Routes

After metabolism, sertraline and its metabolites are eliminated through dual pathways 1:

• 40-45% of administered radioactivity is recovered in urine over 9 days, with unchanged sertraline undetectable in urine 1
• 40-45% is excreted in feces over the same period, including 12-14% as unchanged sertraline 1
• The biliary excretion route accounts for the significant fecal elimination 1

Clinical Implications of the 26-Hour Half-Life

• The average terminal elimination half-life of 26 hours means steady-state is achieved after approximately one week of daily dosing, and conversely, it takes about one week for the drug to be substantially eliminated after discontinuation 1
• There is approximately two-fold accumulation with repeated dosing compared to single doses, reflecting the balance between absorption, distribution, and elimination 1
• The extensive membrane accumulation and long half-life of the N-desmethyl metabolite (62-104 hours) explain why sertraline effects persist well beyond the parent drug's plasma half-life 1, 2

Important Caveat on Intracellular Compartmentalization

• Recent evidence shows sertraline accumulates within neuronal endoplasmic reticulum and membranes at concentrations far exceeding extracellular levels, suggesting that SERT-drug interactions within organelles or membranes may contribute to both therapeutic effects and discontinuation symptoms 2
• This intracellular sequestration means that even after dissociation from SERT at the plasma membrane, significant drug remains within cells and continues to redistribute 2